论文部分内容阅读
本品为新一代抗白内障药,国外于80年代首次由意大利研制开发,随后在20多个国家注册、生产和开展研究。国内由江苏省药物研究所和浙江平湖制药厂合作研制。该研究于1992年被列入“八五”国家重点科技攻关项目,1996年通过国家重点科技项目专题验收,达国内领先水平,1997年9月获卫生部新药证书和生产批件,为国家二类新药。 1 基本属性 1.1 名称 通用名:苄达赖氨酸滴眼液 英文名:Baidazac Lysine Eye Drops(BDZL)商品名:百达克化学名:L-赖氨
This product is a new generation of anti-cataract drugs, developed by Italy for the first time abroad in the 1980s, and subsequently registered, manufactured and carried out research in more than 20 countries. Domestic by the Jiangsu Provincial Institute of Pharmaceutical and Zhejiang Pinghu Pharmaceutical co-developed. The study was included in the “Eighth Five-Year” national key scientific and technological project in 1992, and passed the acceptance of national key scientific and technological projects in 1996, reaching the leading domestic level. In September 1997, it was approved by the Ministry of Health as a new drug certificate and production approval document, New medicine 1 Basic Properties 1.1 Name Common Name: benzyl Daisy Eye Drops English Name: Baidazac Lysine Eye Drops (BDZL) Trade Name: